eXoZymes Secures Another $0.64M in Dilutive Unit Offering with Warrant Reset
EXOZ sits 34% above its 52-week low of $6.33 on elevated volume (7.2× avg).
Summary
EXOZYMES has completed a unit offering, raising $0.64 million in gross proceeds. This small capital infusion follows a $5.3 million offering in early June and a $2 million non-dilutive NIH grant received just last week. The offering includes warrants with a reset feature, which the corresponding SEC filing indicates could lead to extreme dilution. Given the company's previously reported going concern status and urgent need for capital, this continuous pattern of small, dilutive raises highlights ongoing financial strain.
At the time of this announcement, EXOZ was trading at $8.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $77.1M. The 52-week trading range was $6.33 to $18.40. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.